Format

Send to

Choose Destination
Clin Genitourin Cancer. 2019 Oct;17(5):e893-e896. doi: 10.1016/j.clgc.2019.05.026. Epub 2019 May 30.

Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant.

Author information

1
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: m.v.nuland@nki.nl.
2
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
3
Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
4
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
5
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
6
Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

KEYWORDS:

Hepatotoxicity; Liver transplant; Metabolite; Prostate cancer; Therapeutic drug monitoring

PMID:
31248829
DOI:
10.1016/j.clgc.2019.05.026

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center